ATE510025T1 - Verfahren für die detektion von mutationen in nukleinsaüren, und die anwendung in der diagnose von genetischen krankheiten und krebs - Google Patents

Verfahren für die detektion von mutationen in nukleinsaüren, und die anwendung in der diagnose von genetischen krankheiten und krebs

Info

Publication number
ATE510025T1
ATE510025T1 AT05027186T AT05027186T ATE510025T1 AT E510025 T1 ATE510025 T1 AT E510025T1 AT 05027186 T AT05027186 T AT 05027186T AT 05027186 T AT05027186 T AT 05027186T AT E510025 T1 ATE510025 T1 AT E510025T1
Authority
AT
Austria
Prior art keywords
nucleic acid
acid fragment
diagnosis
genetic diseases
cancer
Prior art date
Application number
AT05027186T
Other languages
German (de)
English (en)
Inventor
Jean-Louis Viovy
Claude Houdayer
Dominique Stoppa-Lyonnet
Jeremie Weber
Original Assignee
Inst Curie
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Curie, Centre Nat Rech Scient filed Critical Inst Curie
Application granted granted Critical
Publication of ATE510025T1 publication Critical patent/ATE510025T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT05027186T 2005-12-13 2005-12-13 Verfahren für die detektion von mutationen in nukleinsaüren, und die anwendung in der diagnose von genetischen krankheiten und krebs ATE510025T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05027186A EP1798291B1 (en) 2005-12-13 2005-12-13 Methods and compositions for assaying mutations and/or large scale alterations in nucleic acids and their uses in diagnosis of genetic diseases and cancers

Publications (1)

Publication Number Publication Date
ATE510025T1 true ATE510025T1 (de) 2011-06-15

Family

ID=36293478

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05027186T ATE510025T1 (de) 2005-12-13 2005-12-13 Verfahren für die detektion von mutationen in nukleinsaüren, und die anwendung in der diagnose von genetischen krankheiten und krebs

Country Status (5)

Country Link
US (1) US20070161032A1 (enExample)
EP (1) EP1798291B1 (enExample)
JP (1) JP2007202552A (enExample)
CN (1) CN1982477A (enExample)
AT (1) ATE510025T1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005061728A1 (en) * 2003-12-16 2005-07-07 Institut Curie Methods and compositions for assaying mutations in nucleic acids
BR112012017532A2 (pt) * 2010-02-18 2019-09-24 Hoffmann La Roche "método para determinar um polipeptídeo com uma sequência de aminoácidos mutante, para produzir um poliptedo e uma imunoglobulina"
US20190139628A1 (en) * 2016-04-27 2019-05-09 Arc Bio, Llc Machine learning techniques for analysis of structural variants
CN110982887A (zh) * 2019-12-30 2020-04-10 上海健康医学院 用于lkb1基因突变检测的引物及其应用
DE112022007796T5 (de) * 2022-11-22 2025-07-10 Hitachi High-Tech Corporation Verfahren zum detektieren eines mutantengens

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885432A (en) * 1992-11-05 1999-03-23 Soane Biosciences Un-crosslinked polymeric media for electrophoresis
WO1995016910A1 (en) 1993-12-17 1995-06-22 Perkin-Elmer Corporation Uncharged polymers for separation of biomolecules by capillary electrophoresis
US5994075A (en) * 1996-05-17 1999-11-30 Hexagen Technology Limited Methods for identifying a mutation in a gene of interest without a phenotypic guide
EP0912766B2 (en) * 1996-06-04 2011-12-14 University of Utah Research Foundation Monitoring hybridization during pcr
US20020169309A1 (en) * 1997-08-05 2002-11-14 Gjerde Douglas T. Mutation detection method
WO1999023257A1 (en) * 1997-10-31 1999-05-14 Transgenomic, Inc. Method of detecting mutant dna by mipc and pcr
ATE310103T1 (de) * 1998-08-19 2005-12-15 Bioventures Inc Methode zur bestimmung von polynukleotidsequenzvariationen
DE69928688T2 (de) * 1998-12-09 2006-08-24 Massachusetts Institute Of Technology, Cambridge Verfahren zur identifizierung von punkt mutationen in einem genom
WO2001034839A1 (en) * 1999-11-12 2001-05-17 Dunlop Charles L M Approaches to identify genetic traits
FR2811083B1 (fr) 2000-06-30 2002-11-22 Inst Curie Milieu liquide non-thermosensible pour l'analyse d'especes au sein d'un canal
US20040018497A1 (en) * 2002-07-26 2004-01-29 Warden Craig H Human obesity LIPIN3 polynucleotide and polypeptide sequences and methods of use thereof

Also Published As

Publication number Publication date
EP1798291B1 (en) 2011-05-18
JP2007202552A (ja) 2007-08-16
US20070161032A1 (en) 2007-07-12
EP1798291A1 (en) 2007-06-20
CN1982477A (zh) 2007-06-20

Similar Documents

Publication Publication Date Title
Bellassai et al. Surface plasmon resonance for biomarker detection: advances in non-invasive cancer diagnosis
Chang et al. ‘Genetic heterogeneity'in HER2/neu testing by fluorescence in situ hybridization: a study of 2522 cases
Pedersen et al. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls
JP2004509629A (ja) 腫瘍に対する遺伝子マーカー
Dell’Atti et al. Detection of clinically relevant point mutations by a novel piezoelectric biosensor
CN104593500B (zh) Y染色体中特异性甲基化位点作为癌症诊断标志物的应用
US20120178093A1 (en) Methods of assessing a risk of cancer progression
WO2009149297A1 (en) Diffuse large b-cell lymphoma markers and uses therefor
JP2013509169A (ja) 前立腺癌の診断および病期分類のための非侵襲的マーカーとなる血中ｍｉＲＮＡ
Raucci et al. based screen-printed electrode to detect miRNA-652 associated to triple-negative breast cancer
KR101478826B1 (ko) 신규한 대장암 진단용 마커 및 이를 이용한 대장암 진단 키트
Xiang et al. Periodontitis‐specific molecular signatures in gingival crevicular fluid
CN107142320A (zh) 用于检测肝癌的基因标志物及其用途
WO2006080597A1 (en) Markers for the diagnosis of lung cancer
Hartmann et al. Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques
WO2005103719A3 (en) Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
Wang et al. Tandem hybridization chain reaction and selective coordination enable fluorescence detection of exosomes in lung cancer
Sultana et al. Quantitative analysis of serum cell-free DNA as a predictive and prognostic marker in breast cancer patients
Khadjavi et al. Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins
KR101604178B1 (ko) 약물에 의한 간 손상의 예측 및 진단을 위한 바이오마커
ATE510025T1 (de) Verfahren für die detektion von mutationen in nukleinsaüren, und die anwendung in der diagnose von genetischen krankheiten und krebs
JP2005518790A5 (enExample)
Kristensen et al. Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer
US20030152972A1 (en) Gene expression associated with psychiatric disorders
KR101644682B1 (ko) 전사체학과 단백질체학을 이용한 약물에 의한 간 손상의 예측 및 진단을 위한 바이오마커

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties